Approval · Notice of Compliance 1534 · 2003
ELIGARD: Notice of Compliance 1534
Issued November 6, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1534
- Date
- November 6, 2003
- Company
- Sanofi-Synthelabo Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Luteinizing hormone-releasing hormone agonist analog
Products in this notice
Medicinal ingredients
- LEUPROLIDE ACETATE 10.2 MG per SYR
- LEUPROLIDE ACETATE 28.2 MG per SYR